BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 25040886)

  • 1. Prediagnostic serum levels of inflammatory biomarkers are correlated with future development of lung and esophageal cancer.
    Keeley BR; Islami F; Pourshams A; Poustchi H; Pak JS; Brennan P; Khademi H; Genden EM; Abnet CC; Dawsey SM; Boffetta P; Malekzadeh R; Sikora AG
    Cancer Sci; 2014 Sep; 105(9):1205-11. PubMed ID: 25040886
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating inflammation markers and prospective risk for lung cancer.
    Shiels MS; Pfeiffer RM; Hildesheim A; Engels EA; Kemp TJ; Park JH; Katki HA; Koshiol J; Shelton G; Caporaso NE; Pinto LA; Chaturvedi AK
    J Natl Cancer Inst; 2013 Dec; 105(24):1871-80. PubMed ID: 24249745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated serum granulocyte-macrophage colony-stimulating factor levels during radiotherapy predict favorable outcomes in lung and esophageal cancer.
    Deng G; Hu P; Zhang J; Liu Q; Liang N; Xie J; Qiao L; Luo H; Xu D; Liu F; Yu X; Liu Z; Lv Y; Zhang J
    Oncotarget; 2016 Dec; 7(51):85142-85150. PubMed ID: 27835886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediagnostic circulating inflammation biomarkers and esophageal squamous cell carcinoma: A case-cohort study in Japan.
    Aversa J; Song M; Shimazu T; Inoue M; Charvat H; Yamaji T; Sawada N; Pfeiffer RM; Karimi P; Dawsey SM; Rabkin CS; Tsugane S; Camargo MC
    Int J Cancer; 2020 Aug; 147(3):686-691. PubMed ID: 31671219
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Research on the relationship between serum levels of inflammatory cytokines and non-small cell lung cancer.
    Song XY; Zhou SJ; Xiao N; Li YS; Zhen DZ; Su CY; Liu ZD
    Asian Pac J Cancer Prev; 2013; 14(8):4765-8. PubMed ID: 24083740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytokine and Chemokine Concentration in the Tear of Patients with Age-Related Cataract.
    Engelbrecht C; Sardinha LR; Rizzo LV
    Curr Eye Res; 2020 Sep; 45(9):1101-1106. PubMed ID: 31928443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediagnostic circulating markers of inflammation and risk of oesophageal adenocarcinoma: a study within the National Cancer Institute Cohort Consortium.
    Cook MB; Barnett MJ; Bock CH; Cross AJ; Goodman PJ; Goodman GE; Haiman CA; Khaw KT; McCullough ML; Newton CC; Boutron-Ruault MC; Lund E; Rutegård M; Thornquist MD; Spriggs M; Giffen C; Freedman ND; Kemp T; Kroenke CH; Le Marchand L; Park JY; Simon M; Wilkens LR; Pinto L; Hildesheim A; Campbell PT
    Gut; 2019 Jun; 68(6):960-968. PubMed ID: 30121626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Associations of circulating mediators of inflammation, cell regulation and immune response with esophageal squamous cell carcinoma.
    Camargo MC; Song M; Ito H; Oze I; Koyanagi YN; Kasugai Y; Rabkin CS; Matsuo K
    J Cancer Res Clin Oncol; 2021 Oct; 147(10):2885-2892. PubMed ID: 34128078
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inflammatory Cytokines and Lung Cancer Risk in 3 Prospective Studies.
    Brenner DR; Fanidi A; Grankvist K; Muller DC; Brennan P; Manjer J; Byrnes G; Hodge A; Severi G; Giles GG; Johansson M; Johansson M
    Am J Epidemiol; 2017 Jan; 185(2):86-95. PubMed ID: 27998891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stem cell factor and granulocyte-macrophage-colony stimulating factor as candidates for tumour markers for non-small-cell lung cancer.
    Mroczko B; Szmitkowski M; Niklinski J
    Clin Chem Lab Med; 1999 Oct; 37(10):959-62. PubMed ID: 10616749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical significance of serum macrophage-colony stimulating factor (M-CSF) in esophageal cancer patients and its comparison with classical tumor markers.
    Łukaszewicz-Zajac M; Mroczko B; Kozłowski M; Nikliński J; Laudański J; Szmitkowski M
    Clin Chem Lab Med; 2010 Oct; 48(10):1467-73. PubMed ID: 20604722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum biomarkers in head and neck squamous cell cancer.
    Kaskas NM; Moore-Medlin T; McClure GB; Ekshyyan O; Vanchiere JA; Nathan CA
    JAMA Otolaryngol Head Neck Surg; 2014 Jan; 140(1):5-11. PubMed ID: 24232368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increase of anti-inflammatory cytokines in patients with esophageal cancer after perioperative treatment with G-CSF.
    Hübel K; Mansmann G; Schäfer H; Oberhäuser F; Diehl V; Engert A
    Cytokine; 2000 Dec; 12(12):1797-800. PubMed ID: 11097751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Granulocyte-Colony stimulating factor and macrophage-colony stimulating factor in patients with non-small-cell lung cancer.
    Mroczko B; Szmitkowski M; Niklinski J
    Clin Chem Lab Med; 2001 May; 39(5):374-9. PubMed ID: 11434384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lack of significant association between serum inflammatory cytokine profiles and the presence of colorectal adenoma.
    Henry CJ; Sedjo RL; Rozhok A; Salstrom J; Ahnen D; Levin TR; D'Agostino R; Haffner S; DeGregori J; Byers T
    BMC Cancer; 2015 Mar; 15():123. PubMed ID: 25884547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Global and targeted metabolomics of esophageal squamous cell carcinoma discovers potential diagnostic and therapeutic biomarkers.
    Xu J; Chen Y; Zhang R; Song Y; Cao J; Bi N; Wang J; He J; Bai J; Dong L; Wang L; Zhan Q; Abliz Z
    Mol Cell Proteomics; 2013 May; 12(5):1306-18. PubMed ID: 23397110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and Validation of an Esophageal Squamous Cell Carcinoma Detection Model by Large-Scale MicroRNA Profiling.
    Sudo K; Kato K; Matsuzaki J; Boku N; Abe S; Saito Y; Daiko H; Takizawa S; Aoki Y; Sakamoto H; Niida S; Takeshita F; Fukuda T; Ochiya T
    JAMA Netw Open; 2019 May; 2(5):e194573. PubMed ID: 31125107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Granulocyte colony stimulating factor (G-CSF) and macrophage colony stimulating factor (M-CSF) as potential tumor markers in non small cell lung cancer diagnosis.
    Bahar B; Acedil Ayc Iota B; Çoşkun U; Büyükberber S; Benekli M; Yildiz R
    Asian Pac J Cancer Prev; 2010; 11(3):709-12. PubMed ID: 21039040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pretreatment serum levels of cytokines and cytokine receptors in patients with non-small cell lung cancer, and correlations with clinicopathological features and prognosis. M-CSF - an independent prognostic factor.
    Kaminska J; Kowalska M; Kotowicz B; Fuksiewicz M; Glogowski M; Wojcik E; Chechlinska M; Steffen J
    Oncology; 2006; 70(2):115-25. PubMed ID: 16645324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inflammatory cytokines and non-small cell lung cancer in a CT-scan screening cohort: Background review of the literature.
    DeCotiis C; Hu Y; Greenberg AK; Huie M; Tsay JC; Pass H; Goldberg JD; Rom WN
    Cancer Biomark; 2016; 16(2):219-33. PubMed ID: 26756613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.